Role of insulin-like growth factor-1 signaling pathway in cisplatin-resistant lung cancer cells

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 3, 2012, Pages

  Sun, Yunguang ^a   Zheng, Siyuan ^a   Torossian, Artour ^a   Speirs, Christina K ^a   Schleicher, Stephen ^a   Giacalone, Nicholas J ^a   Carbone, David P ^a   Zhao, Zhongming ^a   Lu, Bo ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cisplatin resistance; IGFBP 3; Insulin like growth factor binding protein 3; Lung cancer; Radiotherapy

Indexed keywords

AFTER-TREATMENT; ALDEHYDE DEHYDROGENASE; CIS-PLATIN; CLONOGENIC ASSAYS; IGFBP-3; IN-VIVO; INSULIN-LIKE GROWTH FACTOR; INSULIN-LIKE GROWTH FACTOR-1; LUNG CANCER; LUNG CANCER CELLS; MICROARRAY ANALYSIS; MICROARRAY EXPRESSIONS; MOLECULAR MECHANISM; NON SMALL CELL LUNG CANCER; RECEPTOR SIGNALING; SIGNALING PATHWAYS; TUMOR GROWTH; WESTERN BLOTS;

ALDEHYDES; BIOLOGICAL ORGANS; CELL DEATH; DISEASES; DRUG PRODUCTS; INSULIN; PEPTIDES; RADIOTHERAPY; TUMORS;

PLATINUM COMPOUNDS;

ALDEHYDE DEHYDROGENASE; CASPASE 3; CD33 ANTIGEN; CISPLATIN; ETOPOSIDE; RINFABATE; SMALL INTERFERING RNA; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER SURVIVAL; CANCER TRANSPLANTATION; CELL LYSATE; CELL SURFACE; CONTROLLED STUDY; DNA METHYLATION; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOSENSITIVITY; RECEPTOR DOWN REGULATION; SENSITIZATION; SIGNAL TRANSDUCTION; STEM CELL; TREATMENT RESPONSE; TUMOR GROWTH;

ALDEHYDE DEHYDROGENASE; ANIMALS; ANTIGENS, CD; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL SURVIVAL; CHEMORADIOTHERAPY; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GLYCOPROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LUNG NEOPLASMS; MICE; MICE, NUDE; MICROARRAY ANALYSIS; PEPTIDES; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; RECEPTOR, IGF TYPE 1; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84856398941     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.06.1999     Document Type: Article

References (24)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. G. Wang, E. Reed, and Q.Q. Li Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer Oncol Rep 12 2004 955 965
3. C.T. Coughlin, and R.C. Richmond Biologic and clinical developments of cisplatin combined with radiation: Concepts, utility, projections for new trials, and the emergence of carboplatin Semin Oncol 16 1989 31 43
4. C.M. De Pooter, P.G. Scalliet, and H.J. Elst Resistance patterns between cis-diamminedichloroplatinum(II) and ionizing radiation Cancer Res 51 1991 4523 4527
5. A.J. Butt, S.M. Firth, and M.A. King Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells J Biol Chem 275 2000 39174 39181
6. H.Y. Lee, K.H. Chun, and B. Liu Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer Cancer Res 62 2002 3530 3537
7. I. Ibanez de Caceres, M. Cortes-Sempere, and C. Moratilla IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer Oncogene 29 2010 1681 1690
8. A.V. Salnikov, J. Gladkich, and G. Moldenhauer CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients Int J Cancer 126 2010 950 958
9. B.M. Bolstad, R.A. Irizarry, and M. Astrand A comparison of normalization methods for high density oligonucleotide array data based on variance and bias Bioinformatics 19 2003 185 193
10. V. Tirino, R. Camerlingo, and R. Franco The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer Eur J Cardiothorac Surg 36 2009 446 453
11. J.S. Moreb, H.V. Baker, and L.J. Chang ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells Mol Cancer 7 2008 87
12. A. Eramo, F. Lotti, and G. Sette Identification and expansion of the tumorigenic lung cancer stem cell population Cell Death Differ 15 2008 504 514
13. X. Meng, M. Li, and X. Wang Both CD133+ and CD133- subpopulations of A549 and H446 cells contain cancer-initiating cells Cancer Sci 100 2009 1040 1046
14. H. Ishii, M. Iwatsuki, and K. Ieta Cancer stem cells and chemoradiation resistance Cancer Sci 99 2008 1871 1877
15. V. Levina, A.M. Marrangoni, and R. DeMarco Drug-selected human lung cancer stem cells: Cytokine network, tumorigenic and metastatic properties PLoS One 3 2008 e3077
16. P. Frit, Y. Canitrot, and C. Muller Cross-resistance to ionizing radiation in a murine leukemic cell line resistant to cis- dichlorodiammineplatinum(II): Role of Ku autoantigen Mol Pharmacol 56 1999 141 146
17. L. Cao, D.N. Petrusca, and M. Satpathy Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling Carcinogenesis 29 2008 1893 1900
18. Y.S. Chang, L. Wang, and D. Liu Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer Clin Cancer Res 8 2002 3669 3675
19. N. Alami, V. Page, and Q. Yu Recombinant human insulin-like growth factor-binding protein 3 inhibits tumor growth and targets the Akt pathway in lung and colon cancer models Growth Horm IGF Res 18 2008 487 496
20. T.W. Miller, M. Perez-Torres, and A. Narasanna Loss of phosphatase and tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer Cancer Res 69 2009 4192 4201
21. T. Iwasa, I. Okamoto, and M. Suzuki Inhibition of insulin-like growth factor 1 receptor by CP-751,871 radiosensitizes non-small cell lung cancer cells Clin Cancer Res 15 2009 5117 5125
22. G.S. Warshamana-Greene, J. Litz, and E. Buchdunger The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy Clin Cancer Res 11 2005 1563 1571
23. J. Zha, and M.R. Lackner Targeting the insulin-like growth factor receptor-1R pathway for cancer therapy Clin Cancer Res 16 2010 2512 2517
24. A. Gualberto, and D.D. Karp Development of the monoclonal antibody figitumumab, targeting the insulin-like growth factor-1 receptor, for the treatment of patients with non-small-cell lung cancer Clin Lung Cancer 10 2009 273 280